US6716883B1
(en)
*
|
1998-12-24 |
2004-04-06 |
1333366 Ontario Inc. |
Composition useful to treat periodontal disease
|
WO2000052020A1
(fr)
*
|
1999-02-26 |
2000-09-08 |
Toyo Suisan Kaisha, Ltd. |
Nouveaux derives du et leur utilisation comme medicaments
|
IT1318425B1
(it)
*
|
2000-03-24 |
2003-08-25 |
D B P Dev Biotechnological Pro |
Impiego del resveratrolo per il trattamento di eczema desquamativo,acne e psoriasi.
|
IT1317034B1
(it)
*
|
2000-05-30 |
2003-05-26 |
Istituto Di Medicina Speriment |
Metodo di estrazione di prodotti ad attivita' farmaceutica da piantespermatofite, prodotti cosi' ottenuti e loro impiego in medicina, in
|
IT1317033B1
(it)
*
|
2000-05-30 |
2003-05-26 |
Istituto Di Medicina Speriment |
Metodo di estrazione di prodotti ad attivita' farmaceutica da piantespermatofite, prodotti cosi' ottenuti e loro impiego in medicina, in
|
ITNA20000036A1
(it)
*
|
2000-06-02 |
2001-12-02 |
Dev Biotechnological Proces Se |
Nuovi approcci terapeutici per il trattamento della forfora.
|
ITNA20000037A1
(it)
*
|
2000-06-02 |
2001-12-02 |
Dev Biotechnological Proces Se |
Filtro solare multifunzione innovativo.
|
FR2812195B1
(fr)
*
|
2000-07-28 |
2003-07-11 |
Oreal |
Compositions a application topique comprenant des hydroxystilbenes glucosyles et utilations
|
US6878751B1
(en)
|
2000-10-19 |
2005-04-12 |
Imperial College Of Science Technology And Medicine |
Administration of resveratrol to treat inflammatory respiratory disorders
|
JP4880816B2
(ja)
*
|
2000-12-15 |
2012-02-22 |
株式会社ヤクルト本社 |
皮膚老化防止剤
|
FR2820975B1
(fr)
*
|
2001-02-21 |
2004-03-12 |
Oreal |
Composition pour application topique comprenant au moins un hydroxystilbene et au moins un polyol pour solubiliser l'hydroxystilbene
|
ITMI20010528A1
(it)
*
|
2001-03-13 |
2002-09-13 |
Istituto Biochimico Pavese Pha |
Complessi di resveratrolo con fosfolipidi loro preparazione e composizioni farmaceutiche e cosmetiche
|
US7384920B2
(en)
*
|
2001-07-26 |
2008-06-10 |
Institute Of Radiation Medicine, Academy Of Military Medical Sciences, Pla |
Use of stilbene compounds in the manufacture of medicament for the prevention and treatment of diabetes or retrovirus-associated diseases
|
WO2003039557A1
(en)
*
|
2001-11-02 |
2003-05-15 |
The Regents Of The University Of California |
Methods and compositions for prevention and treatment of inflammatory disease, autoimmune disease, and transplant rejection
|
US20090208544A1
(en)
*
|
2002-03-20 |
2009-08-20 |
Rachid Ennamany |
Method of obtaining phytoalexins
|
FR2837385B1
(fr)
*
|
2002-03-20 |
2004-05-28 |
Rachid Ennamany |
Procede d'obtention de phytoalexines
|
DE10226990A1
(de)
*
|
2002-06-18 |
2004-03-18 |
Sanguibiotech Ag |
Topisch applizierbare Mikro-Emulsionen mit binärer Phasen- und Wirkstoffdifferenzierbarkeit, deren Herstellung und deren Verwendung, insbesondere zur Versorgung der Haut mit bioverfügbarem Sauerstoff
|
US7977049B2
(en)
*
|
2002-08-09 |
2011-07-12 |
President And Fellows Of Harvard College |
Methods and compositions for extending the life span and increasing the stress resistance of cells and organisms
|
US20050080024A1
(en)
*
|
2002-08-15 |
2005-04-14 |
Joseph Tucker |
Nitric oxide donating derivatives for the treatment of cardiovascular disorders
|
US20050080021A1
(en)
*
|
2002-08-15 |
2005-04-14 |
Joseph Tucker |
Nitric oxide donating derivatives of stilbenes, polyphenols and flavonoids for the treatment of cardiovascular disorders
|
US20040033480A1
(en)
*
|
2002-08-15 |
2004-02-19 |
Wong Norman C.W. |
Use of resveratrol to regulate expression of apolipoprotein A1
|
EP1626702A2
(en)
*
|
2003-05-26 |
2006-02-22 |
Enprani Co., Ltd. |
Whitening and antioxidative cosmetic composition containing resveratrol and method for preparing the same
|
WO2004105517A1
(en)
|
2003-05-27 |
2004-12-09 |
Dsm Ip Assets B.V. |
Novel nutraceutical compositions and use thereof
|
US20060025337A1
(en)
|
2003-07-01 |
2006-02-02 |
President And Fellows Of Harvard College |
Sirtuin related therapeutics and diagnostics for neurodegenerative diseases
|
CA2529510A1
(en)
*
|
2003-07-01 |
2005-01-13 |
President And Fellows Of Harvard College |
Compositions for manipulating the lifespan and stress response of cells and organisms
|
US7758902B2
(en)
*
|
2003-09-12 |
2010-07-20 |
Access Business Group International Llc |
Cytokine modulators and related methods of use
|
KR101245440B1
(ko)
*
|
2003-09-12 |
2013-03-19 |
액세스 비지니스 그룹 인터내셔날 엘엘씨 |
사이토킨 조절물질 및 관련된 용도
|
US7758903B2
(en)
|
2003-09-12 |
2010-07-20 |
Access Business Group International Llc |
Cytokine modulators and related methods of use
|
US9198887B2
(en)
|
2003-09-15 |
2015-12-01 |
Nanopharmaceuticals Llc |
Thyroid hormone analogs and methods of use
|
CA2539288C
(en)
|
2003-09-15 |
2015-05-12 |
Shaker A. Mousa |
Thyroid hormone analogs and methods of use
|
US8668926B1
(en)
|
2003-09-15 |
2014-03-11 |
Shaker A. Mousa |
Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists, and formulations thereof
|
FR2861729B1
(fr)
*
|
2003-10-31 |
2006-09-08 |
Fabre Pierre Dermo Cosmetique |
Monomere d'alkyl-rhamnose ou d'alkyl-fucose, medicament comprenant un monomere d'alkyl-sucre reducteur
|
EP1708689A2
(en)
|
2003-12-29 |
2006-10-11 |
The President and Fellows of Harvard College |
Compositions for treating or preventing obesity and insulin resistance disorders
|
US8017634B2
(en)
|
2003-12-29 |
2011-09-13 |
President And Fellows Of Harvard College |
Compositions for treating obesity and insulin resistance disorders
|
EP1753708B1
(en)
|
2004-01-20 |
2018-02-21 |
Brigham Young University |
Novel sirtuin activating compounds and methods for making the same
|
FR2867977B1
(fr)
*
|
2004-03-26 |
2013-04-12 |
Af Consulting |
Compositions pour limiter les rides de la peau provoquees par les contractions des muscles sous-cutanes et contenant du resveratrol et/ou de ses derives
|
US8338648B2
(en)
*
|
2004-06-12 |
2012-12-25 |
Signum Biosciences, Inc. |
Topical compositions and methods for epithelial-related conditions
|
AU2005262472B2
(en)
*
|
2004-06-16 |
2011-10-27 |
President And Fellows Of Harvard College |
Methods and compositions for modulating bax-mediated apoptosis
|
MX2007003126A
(es)
|
2004-09-14 |
2007-08-02 |
Ajinomoto Omnichem S A |
Composiciones topicas que contienen polifenoles fosforilados.
|
US7846915B2
(en)
*
|
2004-10-20 |
2010-12-07 |
Resverlogix Corporation |
Stilbenes and chalcones for the prevention and treatment of cardiovascular diseases
|
DE502006008551D1
(de)
*
|
2005-02-04 |
2011-02-03 |
Peter Heger |
Verfahren zur herstellung eines hydroxystilben-haltigen drogenextraktes
|
US20060229265A1
(en)
*
|
2005-03-30 |
2006-10-12 |
Sirtris Pharmaceuticals, Inc. |
Nicotinamide riboside and analogues thereof
|
US20070014833A1
(en)
*
|
2005-03-30 |
2007-01-18 |
Sirtris Pharmaceuticals, Inc. |
Treatment of eye disorders with sirtuin modulators
|
US20060277887A1
(en)
*
|
2005-05-31 |
2006-12-14 |
Nutragon, Llc |
Method for processing organic plant matter into dry powder, oil and juice products
|
WO2006138418A2
(en)
*
|
2005-06-14 |
2006-12-28 |
President And Fellows Of Harvard College |
Improvement of cognitive performance with sirtuin activators
|
US20070149466A1
(en)
*
|
2005-07-07 |
2007-06-28 |
Michael Milburn |
Methods and related compositions for treating or preventing obesity, insulin resistance disorders, and mitochondrial-associated disorders
|
AU2006275514B2
(en)
*
|
2005-07-29 |
2012-04-05 |
Resverlogix Corp. |
Pharmaceutical compositions for the prevention and treatment of complex diseases and their delivery by insertable medical devices
|
US9220788B2
(en)
|
2009-06-17 |
2015-12-29 |
Nanopharmaceuticals Llc |
Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists, and formulations and uses thereof
|
US9498536B2
(en)
|
2005-09-15 |
2016-11-22 |
Nanopharmaceuticals Llc |
Method and composition of thyroid hormone analogues and nanoformulations thereof for treating anti-inflammatory disorders
|
US10130686B2
(en)
|
2005-09-15 |
2018-11-20 |
Nanopharmaceuticals Llc |
Method and composition of thyroid hormone analogues and nanoformulations thereof for treating inflammatory disorders
|
US20100209382A1
(en)
*
|
2005-09-16 |
2010-08-19 |
Ordway Research Institute, Inc. |
Polyphenol Conjugates as RGD-Binding Compounds and Methods of Use
|
KR100927579B1
(ko)
*
|
2006-12-13 |
2009-11-23 |
주식회사 엘지생명과학 |
히아루론산 및/또는 그것의 염을 함유하는 아토피성피부염의 개선 및 치료를 위한 조성물
|
AU2007353426A1
(en)
*
|
2006-12-22 |
2008-11-20 |
Albany College Of Pharmacy And Health Sciences |
Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists, and formulations and uses thereof
|
US20080181955A1
(en)
*
|
2007-01-30 |
2008-07-31 |
Webb Lawrence X |
Natural dietary supplement and method for enhancing human libido
|
CN101641339B
(zh)
|
2007-02-01 |
2013-07-17 |
雷斯韦洛吉克斯公司 |
用于预防和治疗心血管疾病的化合物
|
BRPI0704227B1
(pt)
*
|
2007-04-16 |
2019-09-17 |
União Brasileira De Educação E Assistência - Ubea |
Produto Farmacêutico para Modular a Formação Óssea
|
US8344024B2
(en)
|
2007-07-31 |
2013-01-01 |
Elc Management Llc |
Anhydrous cosmetic compositions containing resveratrol derivatives
|
US9295621B2
(en)
|
2007-07-31 |
2016-03-29 |
Elc Management Llc |
Emulsion cosmetic compositions containing resveratrol derivatives and silicone surfactant
|
US8080583B2
(en)
|
2007-07-31 |
2011-12-20 |
Elc Management Llc |
Emulsion cosmetic compositions containing resveratrol derivatives and linear or branched silicone
|
US20090035236A1
(en)
|
2007-07-31 |
2009-02-05 |
Maes Daniel H |
Emulsion Cosmetic Compositions Containing Resveratrol Derivatives And An Oil Phase Structuring Agent
|
US8263051B2
(en)
*
|
2007-08-09 |
2012-09-11 |
Hallstar Innovations Corp. |
Photostabilization of resveratrol with alkoxycrylene compounds
|
US20090047309A1
(en)
*
|
2007-08-13 |
2009-02-19 |
Maes Daniel H |
Cosmetic methods and compositions for repairing human skin
|
US8193155B2
(en)
*
|
2009-02-09 |
2012-06-05 |
Elc Management, Llc |
Method and compositions for treating skin
|
US8703161B2
(en)
*
|
2007-08-13 |
2014-04-22 |
Elc Management, Llc |
Skin repair compositions comprising circadian gene activators and a synergistic combination of Sirt1 gene activators
|
JP5281645B2
(ja)
|
2007-09-08 |
2013-09-04 |
イーエルシー マネージメント エルエルシー |
フェルラ酸レスベラトロール化合物、それらの化合物を含有する組成物およびそれらの使用方法。
|
EP2249806A2
(en)
*
|
2008-01-08 |
2010-11-17 |
Sirtris Pharmaceuticals, Inc. |
Resveratrol formulations
|
ITFI20080019A1
(it)
*
|
2008-02-11 |
2009-08-12 |
Glures S R L |
Formulazioni comprendenti piceide e resveratrolo atte a prevenire e inibire la perossidazione lipidica.
|
JP5684578B2
(ja)
*
|
2008-03-03 |
2015-03-11 |
エヌエーディー ライフ プロプライエタリー リミテッド |
リスベラトロールの医薬製剤、および細胞障害を治療するためのその使用方法
|
CA2629979A1
(en)
*
|
2008-04-25 |
2009-10-25 |
Pharmascience Inc. |
Novel resveratrol compositions
|
KR101629356B1
(ko)
|
2008-06-26 |
2016-06-13 |
리스버로직스 코퍼레이션 |
퀴나졸리논 유도체의 제조방법
|
US20090326000A1
(en)
*
|
2008-06-27 |
2009-12-31 |
Christopher Hull |
Resveratrol formulations and methods of use
|
FR2933871B1
(fr)
*
|
2008-07-18 |
2012-12-14 |
Yvery |
Formulation destinee a ameliorer la biodisponibilite d'une molecule hydrophobe
|
CA2748344A1
(en)
*
|
2008-11-26 |
2010-06-03 |
Lipoprotein Technologies, Inc. |
Enhanced bioactive formulations of resveratrol
|
CA2745376A1
(en)
*
|
2008-12-01 |
2010-06-10 |
Lifespan Extension Llc |
Methods and compositions for altering health, wellbeing, and lifespan
|
US20100159021A1
(en)
*
|
2008-12-23 |
2010-06-24 |
Paul Davis |
Small Molecule Ligands of the Integrin RGD Recognition Site and Methods of Use
|
AU2010204106B2
(en)
|
2009-01-08 |
2014-05-08 |
Resverlogix Corp. |
Compounds for the prevention and treatment of cardiovascular disease
|
MX2021012876A
(es)
|
2009-03-18 |
2022-06-23 |
Resverlogix Corp |
Nuevos agentes anti-inflamatorios.
|
WO2010120506A1
(en)
*
|
2009-03-31 |
2010-10-21 |
Ordway Research Institute, Inc. |
Combination treatment of cancer with cetuximab and tetrac
|
ES2821018T3
(es)
|
2009-04-22 |
2021-04-23 |
Resverlogix Corp |
Nuevos agentes antiinflamatorios
|
CA2763862C
(en)
*
|
2009-06-09 |
2017-04-25 |
Mardi Medicines Ltd. |
Halogenated aliphatic carboxylic acids, oligomers and/or polymers thereof and their use in devitalizing external and internal neoplasms
|
US20110021640A1
(en)
*
|
2009-07-27 |
2011-01-27 |
Kailash Chandra Agarwal |
Mechanism-based biochemical standardization of resveratrol products and their uses thereof
|
JP2011046660A
(ja)
*
|
2009-08-28 |
2011-03-10 |
Fujifilm Corp |
マトリックスメタロプロテアーゼ−2(mmp−2)阻害剤
|
ES2362065B1
(es)
*
|
2009-12-15 |
2012-05-18 |
Consejo Superior De Investigaciones Cient�?Ficas (Csic) |
Compuestos con actividad antiinflamatoria.
|
CA2792993A1
(fr)
*
|
2010-01-21 |
2011-07-28 |
Inserm (Institut National De La Sante Et De La Recherche Medicale) |
Composition particuliere pour son application comme medicament
|
US9962361B2
(en)
|
2011-01-03 |
2018-05-08 |
The William M. Yarbrough Foundation |
Isothiocyanate functional surfactants, formulations incorporating the same, and associated methods of use
|
US8933119B2
(en)
|
2011-01-03 |
2015-01-13 |
The William M. Yarbrough Foundation |
Method for treating phytophotodermatitis
|
US10647668B2
(en)
|
2011-01-03 |
2020-05-12 |
The William M. Yarbrough Foundation |
Isothiocyanate functional surfactant and associated method of use
|
US10308599B2
(en)
|
2011-01-03 |
2019-06-04 |
The William M. Yarbrough Foundation |
Isothiocyanate functional surfactants, formulations incorporating the same, and associated methods of use
|
US10640464B2
(en)
|
2011-01-03 |
2020-05-05 |
The William M. Yarbrough Foundation |
Use of isothiocyanate functional surfactants as Nrf2 inducers to treat epidermolysis bullosa simplex and related diseases
|
US11279674B2
(en)
|
2011-01-03 |
2022-03-22 |
The William M. Yarbrough Foundation |
Isothiocyanate functional surfactant and associated method of use
|
US11407713B2
(en)
|
2011-01-03 |
2022-08-09 |
The William M. Yarbrough Foundation |
Isothiocyanate functional surfactants, formulations incorporating the same, and associated methods of use
|
US10273205B2
(en)
|
2011-01-03 |
2019-04-30 |
The William M. Yarbrough Foundation |
Isothiocyanate functional surfactants, formulations incorporating isothiocyanate functional surfactants and associated methods for treating biofilms
|
US8802240B2
(en)
|
2011-01-06 |
2014-08-12 |
Nanopharmaceuticals Llc |
Uses of formulations of thyroid hormone analogs and nanoparticulate forms thereof to increase chemosensitivity and radiosensitivity in tumor or cancer cells
|
US8865765B2
(en)
|
2011-01-12 |
2014-10-21 |
The William M. Yarbrough Foundation |
Method for treating eczema
|
US9532969B2
(en)
|
2011-02-08 |
2017-01-03 |
The William M. Yarbrough Foundation |
Method for treating psoriasis
|
US8841350B2
(en)
*
|
2011-05-11 |
2014-09-23 |
ChromaDex Inc. |
Method for inducing UDP-glucuronosyltransferase activity using pterostilbene
|
US9254252B2
(en)
|
2011-09-26 |
2016-02-09 |
Dsm Ip Assets B.V. |
Compounds
|
WO2013045384A1
(en)
*
|
2011-09-26 |
2013-04-04 |
Dsm Ip Assets B.V. |
Novel compositions
|
PT2773354T
(pt)
|
2011-11-01 |
2019-07-17 |
Resverlogix Corp |
Formulações orais de libertação imediata para quinazolinonas substituídas
|
IN2014MN01065A
(pt)
|
2011-12-06 |
2015-05-01 |
Unilever Plc |
|
EP2875359A4
(en)
|
2012-03-30 |
2015-08-19 |
Charles R Drew University Of Medicine And Science |
COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING METABOLISM SYNDROME DISEASES
|
US20140005276A1
(en)
*
|
2012-06-29 |
2014-01-02 |
Simarna Kaur |
Compositions comprising substituted phenols and topical application thereof
|
US8758731B2
(en)
|
2012-06-29 |
2014-06-24 |
Johnson & Johnson Consumer Companies, Inc. |
Skin lightening by topical application of 1-hydroxyl 3,5-bis(4′hydroxyl styryl)benzene
|
US8846013B2
(en)
|
2012-06-29 |
2014-09-30 |
Johnson & Johnson Consumer Companies, Inc. |
Topical application of 1-hydroxyl-3,5-BIS(4′hydroxy styryl)benzene
|
US10080734B2
(en)
|
2012-07-26 |
2018-09-25 |
The William M. Yarbrough Foundation |
Method for treating autism and other neurodevelopmental disorders
|
US10335387B2
(en)
|
2012-07-26 |
2019-07-02 |
The William M. Yarbrough Foundation |
Method for treating infectious diseases with isothiocyanate functional compounds
|
US10441561B2
(en)
|
2012-07-26 |
2019-10-15 |
The William M. Yanbrough Foundation |
Method for treating benign prostatic hyperplasia (BPH), prostatitis, and prostate cancer
|
US10434082B2
(en)
|
2012-07-26 |
2019-10-08 |
The William M. Yarbrough Foundation |
Isothiocyanate functional compounds augmented with secondary antineoplastic medicaments and associated methods for treating neoplasms
|
US8865772B2
(en)
|
2012-07-26 |
2014-10-21 |
The William M. Yarbrough Foundation |
Method for treating skin cancer
|
US9949943B2
(en)
|
2012-07-26 |
2018-04-24 |
The William M. Yarbrough Foundation |
Method for treating neurodegenerative diseases
|
US9839621B2
(en)
|
2012-07-26 |
2017-12-12 |
The William M. Yarbrough Foundation |
Method for treating bladder cancer
|
US10434081B2
(en)
|
2012-07-26 |
2019-10-08 |
The William M. Yarbrough Foundation |
Inhibitors of macrophage migration inhibitory factor
|
US10383815B2
(en)
|
2012-09-14 |
2019-08-20 |
Elc Management Llc |
Method and compositions for improving selective catabolysis in cells of keratin surfaces
|
WO2014080291A2
(en)
|
2012-11-21 |
2014-05-30 |
Rvx Therapeutics Inc. |
Biaryl derivatives as bromodomain inhibitors
|
US9073878B2
(en)
|
2012-11-21 |
2015-07-07 |
Zenith Epigenetics Corp. |
Cyclic amines as bromodomain inhibitors
|
CN103006627B
(zh)
*
|
2012-11-30 |
2014-06-11 |
曾小峰 |
白藜芦醇在制备用于预防和/或治疗系统性红斑狼疮的组合物中的用途
|
AU2013365926B9
(en)
|
2012-12-21 |
2019-01-17 |
Zenith Epigenetics Ltd. |
Novel heterocyclic compounds as bromodomain inhibitors
|
CN113350324A
(zh)
*
|
2013-08-21 |
2021-09-07 |
协和大学 |
树状聚合物-白藜芦醇复合物
|
WO2015074050A1
(en)
|
2013-11-18 |
2015-05-21 |
Nanopharmaceuticals Llc |
Methods for screening patients for resistance to angioinhibition, treatment and prophylaxis thereof
|
US10111885B2
(en)
|
2015-03-13 |
2018-10-30 |
Resverlogix Corp. |
Compositions and therapeutic methods for the treatment of complement-associated diseases
|
MX2018002851A
(es)
|
2015-09-07 |
2019-01-14 |
Medskin Solutions Dr Suwelack Ag |
Composicion para aplicacion topica que comprende dimetil isosorbida, un poliol y un antioxidante fenolico o polifenolico.
|
WO2017194590A1
(en)
|
2016-05-10 |
2017-11-16 |
Basf Se |
Process for the manufacture of hydroxy-substituted aromatic compounds
|
EP3463477A4
(en)
|
2016-06-07 |
2020-03-04 |
NanoPharmaceuticals LLC |
NON-CLeavable POLYMER CONJUGATED WITH THYROID ANTAGONISTS OF avß3 INTEGRIN
|
ES2673942B1
(es)
|
2016-11-23 |
2019-04-09 |
Consejo Superior Investigacion |
Compuestos acilados para el tratamiento de patologias oculares
|
US10456343B2
(en)
*
|
2017-01-26 |
2019-10-29 |
L'oreal |
Microemulsion compositions comprising polydatin and method of use
|
US11103465B2
(en)
*
|
2017-11-22 |
2021-08-31 |
Ted's Brain Science, Inc. |
Trans-resveratrol topical medication for the treatment of pain and method of manufacture thereof
|
US11351137B2
(en)
|
2018-04-11 |
2022-06-07 |
Nanopharmaceuticals Llc |
Composition and method for dual targeting in treatment of neuroendocrine tumors
|
US10328043B1
(en)
|
2018-04-11 |
2019-06-25 |
Nanopharmaceuticals, Llc. |
Composition and method for dual targeting in treatment of neuroendocrine tumors
|
CN109602702A
(zh)
*
|
2019-01-02 |
2019-04-12 |
遵义医学院 |
一种具有脑靶向作用的白藜芦醇纳米粒及其制备工艺
|
EP3941449A1
(en)
*
|
2019-03-20 |
2022-01-26 |
Rita Dobmeyer |
Pharmaceutical composition
|
US10961204B1
(en)
|
2020-04-29 |
2021-03-30 |
Nanopharmaceuticals Llc |
Composition of scalable thyrointegrin antagonists with improved blood brain barrier penetration and retention into brain tumors
|
CN112843113B
(zh)
*
|
2021-03-23 |
2022-02-01 |
南京医科大学 |
一种用于治疗接触性皮炎的制剂
|
US11723888B2
(en)
|
2021-12-09 |
2023-08-15 |
Nanopharmaceuticals Llc |
Polymer conjugated thyrointegrin antagonists
|
WO2023244738A1
(en)
*
|
2022-06-15 |
2023-12-21 |
The Johns Hopkins University |
Thiazolidinediones for the treatment of muscular dystrophies
|